| 0 |
DEVICE CATCHING FIRE |
1 |
0.1111 |
| 1 |
SWOLLEN JOINT COUNT |
5 |
0.0200 |
| 2 |
MUSCLE INJURY |
146 |
0.0176 |
| 3 |
BREAST PROSTHESIS USER |
1 |
0.0161 |
| 4 |
FOLLICULITIS |
154 |
0.0147 |
| 5 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
103 |
0.0144 |
| 6 |
ACQUIRED PORPHYRIA |
1 |
0.0141 |
| 7 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
84 |
0.0129 |
| 8 |
DUODENAL ULCER PERFORATION |
96 |
0.0129 |
| 9 |
HELICOBACTER INFECTION |
111 |
0.0108 |
| 10 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
6 |
0.0107 |
| 11 |
SALPINGO-OOPHORECTOMY UNILATERAL |
1 |
0.0091 |
| 12 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
17 |
0.0085 |
| 13 |
PEMPHIGUS |
106 |
0.0085 |
| 14 |
MUSCLE SPASTICITY |
104 |
0.0085 |
| 15 |
SALPINGO-OOPHORECTOMY |
1 |
0.0084 |
| 16 |
DISLOCATION OF VERTEBRA |
18 |
0.0079 |
| 17 |
X-RAY ABNORMAL |
14 |
0.0078 |
| 18 |
HAND DEFORMITY |
95 |
0.0072 |
| 19 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
15 |
0.0072 |
| 20 |
SWOLLEN JOINT COUNT INCREASED |
23 |
0.0072 |
| 21 |
IRRITABLE BOWEL SYNDROME |
152 |
0.0071 |
| 22 |
URTICARIA THERMAL |
1 |
0.0070 |
| 23 |
C-REACTIVE PROTEIN |
6 |
0.0065 |
| 24 |
FACET JOINT SYNDROME |
21 |
0.0064 |
| 25 |
CAUSTIC INJURY |
2 |
0.0064 |
| 26 |
PERICARDITIS |
107 |
0.0064 |
| 27 |
PORPHYRIA ACUTE |
9 |
0.0063 |
| 28 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
4 |
0.0060 |
| 29 |
RHEUMATIC FEVER |
26 |
0.0058 |
| 30 |
SYNOVITIS |
105 |
0.0058 |
| 31 |
EAR PAIN |
109 |
0.0056 |
| 32 |
LUPUS VULGARIS |
7 |
0.0056 |
| 33 |
RHEUMATOID FACTOR POSITIVE |
32 |
0.0055 |
| 34 |
PERIPHERAL VENOUS DISEASE |
21 |
0.0051 |
| 35 |
BODY TEMPERATURE INCREASED |
102 |
0.0050 |
| 36 |
IMPAIRED HEALING |
156 |
0.0047 |
| 37 |
LOWER RESPIRATORY TRACT INFECTION |
205 |
0.0045 |
| 38 |
GRIP STRENGTH |
1 |
0.0044 |
| 39 |
GLOSSODYNIA |
96 |
0.0043 |
| 40 |
RETINITIS |
7 |
0.0040 |
| 41 |
APPLICATION SITE BLEEDING |
1 |
0.0040 |
| 42 |
CONTRAINDICATED PRODUCT ADMINISTERED |
122 |
0.0040 |
| 43 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
14 |
0.0037 |
| 44 |
NIGHT SWEATS |
115 |
0.0036 |
| 45 |
BURNS FIRST DEGREE |
1 |
0.0035 |
| 46 |
RESPIRATORY DISORDER |
103 |
0.0034 |
| 47 |
C-REACTIVE PROTEIN ABNORMAL |
21 |
0.0033 |
| 48 |
BREAST CANCER STAGE III |
19 |
0.0029 |
| 49 |
URETERAL STENT INSERTION |
1 |
0.0029 |
| 50 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
99 |
0.0028 |
| 51 |
LIP DRY |
25 |
0.0027 |
| 52 |
BLISTER |
151 |
0.0027 |
| 53 |
SERONEGATIVE ARTHRITIS |
3 |
0.0026 |
| 54 |
STOMATITIS |
155 |
0.0026 |
| 55 |
WOUND |
62 |
0.0022 |
| 56 |
ALLERGY TEST POSITIVE |
1 |
0.0022 |
| 57 |
SYNOVIAL DISORDER |
1 |
0.0022 |
| 58 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
96 |
0.0021 |
| 59 |
APPLICATION SITE DERMATITIS |
2 |
0.0021 |
| 60 |
DRUG TOLERANCE DECREASED |
6 |
0.0021 |
| 61 |
SINUSITIS |
211 |
0.0021 |
| 62 |
JOINT RANGE OF MOTION DECREASED |
27 |
0.0020 |
| 63 |
ILL-DEFINED DISORDER |
121 |
0.0020 |
| 64 |
APPLICATION SITE INFECTION |
1 |
0.0020 |
| 65 |
GRIP STRENGTH DECREASED |
17 |
0.0019 |
| 66 |
WOUND INFECTION |
21 |
0.0019 |
| 67 |
BURSITIS |
22 |
0.0018 |
| 68 |
ARTHROPATHY |
99 |
0.0018 |
| 69 |
EJECTION FRACTION |
1 |
0.0017 |
| 70 |
WALKING AID USER |
11 |
0.0017 |
| 71 |
AUTOIMMUNE DISORDER |
16 |
0.0016 |
| 72 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
28 |
0.0016 |
| 73 |
SWELLING |
151 |
0.0016 |
| 74 |
GASTROINTESTINAL DISORDER |
144 |
0.0016 |
| 75 |
SLEEP DISORDER |
113 |
0.0016 |
| 76 |
INFUSION RELATED REACTION |
106 |
0.0016 |
| 77 |
HEPATIC ENZYME INCREASED |
106 |
0.0016 |
| 78 |
IATROGENIC INJURY |
2 |
0.0016 |
| 79 |
JOINT SWELLING |
186 |
0.0015 |
| 80 |
DISCOMFORT |
91 |
0.0015 |
| 81 |
HIP ARTHROPLASTY |
22 |
0.0014 |
| 82 |
INFUSION SITE INFLAMMATION |
1 |
0.0014 |
| 83 |
BONE EROSION |
5 |
0.0014 |
| 84 |
PREGNANCY |
28 |
0.0014 |
| 85 |
OBESITY |
22 |
0.0014 |
| 86 |
CAUDA EQUINA SYNDROME |
1 |
0.0013 |
| 87 |
CONTUSION |
122 |
0.0013 |
| 88 |
LIVE BIRTH |
10 |
0.0012 |
| 89 |
TYMPANIC MEMBRANE PERFORATION |
2 |
0.0012 |
| 90 |
PERIPHERAL SWELLING |
180 |
0.0012 |
| 91 |
BURNS SECOND DEGREE |
2 |
0.0011 |
| 92 |
PSORIATIC ARTHROPATHY |
46 |
0.0011 |
| 93 |
SPONDYLITIS |
4 |
0.0011 |
| 94 |
CONTRAST MEDIA ALLERGY |
2 |
0.0011 |
| 95 |
BREAST CANCER STAGE II |
9 |
0.0011 |
| 96 |
INFECTION |
152 |
0.0010 |
| 97 |
MEDICATION ERROR |
58 |
0.0010 |
| 98 |
HYPERCHOLESTEROLAEMIA |
10 |
0.0010 |
| 99 |
FIBROMYALGIA |
25 |
0.0010 |
| 100 |
LOWER LIMB FRACTURE |
19 |
0.0010 |
| 101 |
KNEE ARTHROPLASTY |
20 |
0.0009 |
| 102 |
APPLICATION SITE PAPULES |
1 |
0.0009 |
| 103 |
SCIATICA |
15 |
0.0009 |
| 104 |
LIVER INJURY |
23 |
0.0009 |
| 105 |
CONFUSIONAL STATE |
150 |
0.0009 |
| 106 |
TYPE 2 DIABETES MELLITUS |
31 |
0.0009 |
| 107 |
OCULAR TOXICITY |
1 |
0.0009 |
| 108 |
GASTRIC POLYPS |
2 |
0.0009 |
| 109 |
PUSTULAR PSORIASIS |
3 |
0.0009 |
| 110 |
ORAL PRURITUS |
2 |
0.0009 |
| 111 |
CHEMICAL BURN |
1 |
0.0009 |
| 112 |
RASH VESICULAR |
4 |
0.0008 |
| 113 |
NASOPHARYNGITIS |
152 |
0.0008 |
| 114 |
HYPERSENSITIVITY |
153 |
0.0008 |
| 115 |
STAPHYLOCOCCAL SKIN INFECTION |
1 |
0.0008 |
| 116 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
2 |
0.0008 |
| 117 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 118 |
DRUG INTOLERANCE |
77 |
0.0008 |
| 119 |
URTICARIA |
132 |
0.0008 |
| 120 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
2 |
0.0008 |
| 121 |
ADJUSTMENT DISORDER |
1 |
0.0008 |
| 122 |
EXOSTOSIS |
7 |
0.0008 |
| 123 |
PRESCRIBED UNDERDOSE |
15 |
0.0008 |
| 124 |
INFUSION SITE RASH |
1 |
0.0007 |
| 125 |
PRESCRIBED OVERDOSE |
14 |
0.0007 |
| 126 |
DEVICE RELATED INFECTION |
11 |
0.0007 |
| 127 |
PREMATURE BABY |
21 |
0.0007 |
| 128 |
WEIGHT INCREASED |
156 |
0.0007 |
| 129 |
PULMONARY FIBROSIS |
13 |
0.0007 |
| 130 |
INSOMNIA |
179 |
0.0007 |
| 131 |
MYOSITIS |
6 |
0.0007 |
| 132 |
EYE INJURY |
2 |
0.0007 |
| 133 |
OTITIS MEDIA |
2 |
0.0006 |
| 134 |
DELIRIUM |
21 |
0.0006 |
| 135 |
GAIT INABILITY |
20 |
0.0006 |
| 136 |
INTENTIONAL PRODUCT USE ISSUE |
52 |
0.0006 |
| 137 |
RHEUMATOID ARTHRITIS |
66 |
0.0006 |
| 138 |
CAROTID ARTERY STENOSIS |
2 |
0.0006 |
| 139 |
ABDOMINAL DISCOMFORT |
95 |
0.0006 |
| 140 |
OSTEOARTHRITIS |
24 |
0.0006 |
| 141 |
WHEEZING |
33 |
0.0006 |
| 142 |
GENERAL SYMPTOM |
4 |
0.0005 |
| 143 |
INTERVERTEBRAL DISCITIS |
1 |
0.0005 |
| 144 |
ALOPECIA |
103 |
0.0005 |
| 145 |
ABDOMINAL PAIN UPPER |
107 |
0.0005 |
| 146 |
BLOOD CHOLESTEROL INCREASED |
24 |
0.0005 |
| 147 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 148 |
ROAD TRAFFIC ACCIDENT |
21 |
0.0005 |
| 149 |
PRURITUS |
192 |
0.0005 |
| 150 |
OEDEMA |
27 |
0.0005 |
| 151 |
SPINAL FUSION SURGERY |
2 |
0.0005 |
| 152 |
APPLICATION SITE DISCOLOURATION |
2 |
0.0005 |
| 153 |
APPLICATION SITE EXFOLIATION |
2 |
0.0005 |
| 154 |
BLEPHAROSPASM |
3 |
0.0005 |
| 155 |
MATERNAL EXPOSURE DURING PREGNANCY |
42 |
0.0005 |
| 156 |
LUNG DISORDER |
23 |
0.0005 |
| 157 |
THERAPY NON-RESPONDER |
21 |
0.0005 |
| 158 |
INFLAMMATION |
24 |
0.0005 |
| 159 |
APPLICATION SITE VESICLES |
3 |
0.0005 |
| 160 |
NAIL DISORDER |
4 |
0.0005 |
| 161 |
CORNEAL DISORDER |
1 |
0.0005 |
| 162 |
INJURY |
32 |
0.0005 |
| 163 |
DISABILITY |
9 |
0.0005 |
| 164 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
5 |
0.0005 |
| 165 |
FOOT DEFORMITY |
5 |
0.0005 |
| 166 |
PYREXIA |
153 |
0.0004 |
| 167 |
LUPUS-LIKE SYNDROME |
4 |
0.0004 |
| 168 |
BACK PAIN |
101 |
0.0004 |
| 169 |
BLOOD PRESSURE DIASTOLIC INCREASED |
2 |
0.0004 |
| 170 |
RASH |
188 |
0.0004 |
| 171 |
LIVER DISORDER |
19 |
0.0004 |
| 172 |
APPLICATION SITE BURN |
2 |
0.0004 |
| 173 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 174 |
MOBILITY DECREASED |
28 |
0.0004 |
| 175 |
TREATMENT FAILURE |
32 |
0.0004 |
| 176 |
MUSCULOSKELETAL PAIN |
20 |
0.0004 |
| 177 |
TENOSYNOVITIS |
1 |
0.0004 |
| 178 |
MUSCULOSKELETAL STIFFNESS |
31 |
0.0004 |
| 179 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
6 |
0.0004 |
| 180 |
PRODUCT LABEL CONFUSION |
2 |
0.0003 |
| 181 |
ARTHRALGIA |
142 |
0.0003 |
| 182 |
PAIN |
206 |
0.0003 |
| 183 |
GENERAL PHYSICAL HEALTH DETERIORATION |
35 |
0.0003 |
| 184 |
ASTHENIA |
112 |
0.0003 |
| 185 |
BREAST MASS |
2 |
0.0003 |
| 186 |
FREQUENT BOWEL MOVEMENTS |
8 |
0.0003 |
| 187 |
DRY MOUTH |
24 |
0.0003 |
| 188 |
ULCER HAEMORRHAGE |
2 |
0.0003 |
| 189 |
WOUND COMPLICATION |
1 |
0.0003 |
| 190 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 191 |
SCRATCH |
3 |
0.0003 |
| 192 |
JOINT DISLOCATION |
3 |
0.0003 |
| 193 |
APPENDICECTOMY |
1 |
0.0003 |
| 194 |
VOMITING |
123 |
0.0003 |
| 195 |
WHITE BLOOD CELL COUNT INCREASED |
10 |
0.0003 |
| 196 |
WOUND SECRETION |
1 |
0.0003 |
| 197 |
COLITIS ULCERATIVE |
11 |
0.0002 |
| 198 |
AMNESIA |
16 |
0.0002 |
| 199 |
ONYCHOMADESIS |
1 |
0.0002 |
| 200 |
FOETAL EXPOSURE DURING PREGNANCY |
19 |
0.0002 |
| 201 |
DYSPNOEA |
130 |
0.0002 |
| 202 |
APPLICATION SITE ERYTHEMA |
6 |
0.0002 |
| 203 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 204 |
EAR INFECTION |
6 |
0.0002 |
| 205 |
EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 206 |
OSTEOPOROSIS |
9 |
0.0002 |
| 207 |
APPLICATION SITE RASH |
3 |
0.0002 |
| 208 |
UROSEPSIS |
2 |
0.0002 |
| 209 |
HEPATIC CIRRHOSIS |
4 |
0.0002 |
| 210 |
FINGER DEFORMITY |
1 |
0.0002 |
| 211 |
ADVERSE EVENT |
19 |
0.0002 |
| 212 |
LABORATORY TEST ABNORMAL |
6 |
0.0002 |
| 213 |
OVARIAN CYST |
2 |
0.0002 |
| 214 |
FATIGUE |
152 |
0.0002 |
| 215 |
HEADACHE |
122 |
0.0002 |
| 216 |
C-REACTIVE PROTEIN INCREASED |
7 |
0.0002 |
| 217 |
JOINT STIFFNESS |
5 |
0.0002 |
| 218 |
SENSITIVITY TO WEATHER CHANGE |
1 |
0.0002 |
| 219 |
PANCREATITIS |
10 |
0.0002 |
| 220 |
PREMATURE DELIVERY |
3 |
0.0002 |
| 221 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
9 |
0.0002 |
| 222 |
RECTAL HAEMORRHAGE |
8 |
0.0002 |
| 223 |
BACK DISORDER |
3 |
0.0002 |
| 224 |
ASTHENOPIA |
1 |
0.0002 |
| 225 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 226 |
RALES |
1 |
0.0002 |
| 227 |
DIARRHOEA |
111 |
0.0002 |
| 228 |
CATARACT OPERATION |
1 |
0.0002 |
| 229 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 230 |
EPILEPSY |
5 |
0.0002 |
| 231 |
DYSPEPSIA |
16 |
0.0002 |
| 232 |
MUSCULAR WEAKNESS |
18 |
0.0002 |
| 233 |
OEDEMA PERIPHERAL |
19 |
0.0002 |
| 234 |
HYPERTENSION |
33 |
0.0002 |
| 235 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
1 |
0.0002 |
| 236 |
HIATUS HERNIA |
2 |
0.0002 |
| 237 |
PRODUCT USE ISSUE |
28 |
0.0001 |
| 238 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 239 |
TASTE DISORDER |
3 |
0.0001 |
| 240 |
HYPOAESTHESIA |
22 |
0.0001 |
| 241 |
ADVERSE DRUG REACTION |
13 |
0.0001 |
| 242 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 243 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 244 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 245 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 246 |
SENSITIVE SKIN |
1 |
0.0001 |
| 247 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 248 |
ABDOMINAL PAIN |
31 |
0.0001 |
| 249 |
APPLICATION SITE PRURITUS |
3 |
0.0001 |
| 250 |
MEMORY IMPAIRMENT |
18 |
0.0001 |
| 251 |
FEELING HOT |
8 |
0.0001 |
| 252 |
DRUG-INDUCED LIVER INJURY |
4 |
0.0001 |
| 253 |
PARAESTHESIA |
20 |
0.0001 |
| 254 |
MIGRAINE |
12 |
0.0001 |
| 255 |
ASTHMA |
14 |
0.0001 |
| 256 |
HYSTERECTOMY |
1 |
0.0001 |
| 257 |
SKIN IRRITATION |
5 |
0.0001 |
| 258 |
CHEST PAIN |
20 |
0.0001 |
| 259 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 260 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 261 |
CONDITION AGGRAVATED |
31 |
0.0001 |
| 262 |
COELIAC DISEASE |
1 |
0.0001 |
| 263 |
ARTHRITIS |
8 |
0.0001 |
| 264 |
DRUG INEFFECTIVE |
134 |
0.0001 |
| 265 |
DEPRESSION |
23 |
0.0001 |
| 266 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 267 |
DECREASED APPETITE |
22 |
0.0001 |
| 268 |
MUSCLE SPASMS |
17 |
0.0001 |
| 269 |
BACK INJURY |
1 |
0.0001 |
| 270 |
OFF LABEL USE |
80 |
0.0001 |
| 271 |
ANAPHYLACTIC REACTION |
5 |
0.0001 |
| 272 |
SNEEZING |
2 |
0.0001 |
| 273 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 274 |
UPPER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 275 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 276 |
UNDERDOSE |
6 |
0.0001 |
| 277 |
PRODUCT USE IN UNAPPROVED INDICATION |
20 |
0.0001 |
| 278 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 279 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 280 |
FLUID RETENTION |
4 |
0.0001 |
| 281 |
ADVERSE REACTION |
1 |
0.0001 |
| 282 |
WEIGHT DECREASED |
21 |
0.0001 |
| 283 |
GAIT DISTURBANCE |
14 |
0.0001 |
| 284 |
SKIN REACTION |
1 |
0.0001 |
| 285 |
HERPES ZOSTER |
4 |
0.0001 |
| 286 |
PULMONARY MASS |
1 |
0.0001 |
| 287 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 288 |
METASTASES TO BONE |
1 |
0.0001 |
| 289 |
HEART RATE DECREASED |
2 |
0.0001 |
| 290 |
ANXIETY |
16 |
0.0001 |
| 291 |
RASH PRURITIC |
3 |
0.0001 |
| 292 |
OSTEOMYELITIS |
1 |
0.0001 |
| 293 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 294 |
HOSPITALISATION |
8 |
0.0001 |
| 295 |
PAIN IN EXTREMITY |
15 |
0.0001 |
| 296 |
MALAISE |
22 |
0.0001 |
| 297 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 298 |
DIZZINESS |
24 |
0.0000 |
| 299 |
DERMATITIS |
1 |
0.0000 |
| 300 |
PNEUMONIA |
15 |
0.0000 |
| 301 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 302 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 303 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 304 |
HEPATOTOXICITY |
1 |
0.0000 |
| 305 |
RASH PAPULAR |
1 |
0.0000 |
| 306 |
BRONCHITIS |
3 |
0.0000 |
| 307 |
VISUAL IMPAIRMENT |
5 |
0.0000 |
| 308 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 309 |
HEPATITIS |
1 |
0.0000 |
| 310 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 311 |
ERYTHEMA |
8 |
0.0000 |
| 312 |
SKIN ULCER |
1 |
0.0000 |
| 313 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 314 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 315 |
PAIN OF SKIN |
1 |
0.0000 |
| 316 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 317 |
SKIN LESION |
1 |
0.0000 |
| 318 |
NAUSEA |
27 |
0.0000 |
| 319 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 320 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 321 |
PSORIASIS |
4 |
0.0000 |
| 322 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 323 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 324 |
HYPOXIA |
1 |
0.0000 |
| 325 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 326 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 327 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 328 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 329 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 330 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 331 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 332 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 333 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 334 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 335 |
LEUKOPENIA |
1 |
0.0000 |
| 336 |
AGGRESSION |
1 |
0.0000 |
| 337 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 338 |
ECZEMA |
1 |
0.0000 |
| 339 |
DEPRESSED MOOD |
1 |
0.0000 |
| 340 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 341 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 342 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 343 |
NECK PAIN |
1 |
0.0000 |
| 344 |
EYE PAIN |
1 |
0.0000 |
| 345 |
IRRITABILITY |
1 |
0.0000 |
| 346 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 347 |
SWELLING FACE |
1 |
0.0000 |
| 348 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 349 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 350 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 351 |
BURNING SENSATION |
1 |
0.0000 |
| 352 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 353 |
EPISTAXIS |
1 |
0.0000 |
| 354 |
HOT FLUSH |
1 |
0.0000 |
| 355 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 356 |
MYALGIA |
2 |
0.0000 |
| 357 |
TACHYCARDIA |
1 |
0.0000 |
| 358 |
DEVICE ISSUE |
1 |
0.0000 |
| 359 |
SOMNOLENCE |
2 |
0.0000 |
| 360 |
FLUSHING |
1 |
0.0000 |
| 361 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 362 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 363 |
FEELING ABNORMAL |
2 |
0.0000 |
| 364 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 365 |
DRY SKIN |
1 |
0.0000 |
| 366 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 367 |
HYPOTENSION |
1 |
0.0000 |
| 368 |
OVERDOSE |
1 |
0.0000 |
| 369 |
COUGH |
1 |
0.0000 |
| 370 |
FALL |
1 |
0.0000 |
| 371 |
DEATH |
1 |
0.0000 |